Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0QW0 stock hub

LON/0QW0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QW0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

36B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QW0

In the news

Latest news · LON/0QW0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25

P25 12.9P50 16.9P75 23.5

Trailing P/E32

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC44.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QW0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

166

Groups with data

Currency

USD

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	UK
Employees	1,863
Employees Change	264%
Employees Change Percent	16.51
Enterprise value	EUR 32.7B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	NL0010832176
Last refreshed	2026-05-10
Market cap	EUR 36B
Price	EUR 670
Price currency	EUR
Rev Per Employee	1,927,802.19x
Sector	Healthcare
Sic	2836
Symbol	lon/0QW0
Website	https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.13%
EV Earnings	29.04x
EV/EBIT	33.69x
EV/EBITDA	33.2x
EV/Sales	9.22x
Forward P/E	25.02x
P/B ratio	6.5x
P/E ratio	31.95x
P/S ratio	10.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.61%
EBITDA Margin	27.8%
Gross margin	58.11%
Gross Profit	EUR 2.1B
Gross Profit Growth	110.26%
Gross Profit Growth Q	79.4%
Net Income	EUR 1.1B
Net Income Growth	39.93%
Net Income Growth Q	115.97%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	31.68%
Profit Margin	31.4%
Profit Per Employee	EUR 605,289
Profitable Years	1
Roa5y	-4.42
Roe5y	-3.39
ROIC	44.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	49.67%
Cagr1y	21.94%
Cagr3y	22.26%
Cagr5y	25.17%
EPS Growth	41.13
EPS Growth Q	114
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	79.43x
Revenue Growth Q	62.63x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	95.02x
Revenue Growth5 Y	87.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 3.4B
Debt	EUR 35.7M
Debt EBITDA	EUR 0.04
Debt Equity	EUR 0.01
Equity	EUR 5.5B
Interest Coverage	412.5
Net Cash	EUR 3.3B
Net Cash By Market Cap	EUR 9.23
Net Cash Growth	31.53%
Net Debt EBITDA	EUR -3.33
Net Debt Equity	EUR -0.6
Tangible Book Value	EUR 5.3B
Tangible Book Value Per Share	EUR 86.29
WACC	3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	5,538.05%
1Y total return	21.93%
200-day SMA	674.7
3Y total return	82.76%
50-day SMA	652.1
50-day SMA vs 200-day SMA	50under200
5Y total return	207.22%
All Time High	809.8
All Time High Change	-17.29%
All Time High Date	2025-11-20
All Time Low	9.3
All Time Low Change	7,102.15%
All Time Low Date	2015-11-30
ATR	22.83
Beta	-0.06
Ch YTD	-6.43
High	676.4
High52	809.8
High52 Date	2025-11-20
High52ch	-17.29%
Low	662.6
Low52	456.8
Low52 Date	2025-07-09
Low52ch	46.63%
Ma50ch	2.72%
Price vs 200-day SMA	-0.72%
RSI	49.06
RSI Monthly	58.79
RSI Weekly	49.92
Sharpe ratio	1.03x
Sortino ratio	1.83
Total Return	0.85%
Tr YTD	-6.43
Tr1m	3.27%
Tr1w	-0.71%
Tr3m	-3.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 991.8M
Operating Income Growth	509
Operating Income Growth Q	178.9
Operating margin	27.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,086,042%
Shares Insiders	0.16%
Shares Institutions	74.66%
Shares Qo Q	-0.11%
Shares Yo Y	-0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	38,350.75x
Bv Per Share	89.62
Ch10y	5,538
Ch1m	3.27
Ch1w	-0.71
Ch1y	21.93
Ch3m	-3.48
Ch3y	82.76
Ch5y	207.2
Ch6m	-8.78
Change	-0.81%
Change From Open	-0.27
Close	675.3
Days Gap	-0.55
Depreciation Amortization	6,363,417.3
Dollar Volume	10,700,724.8
Earnings Date	2026-05-07
EBIT	EUR 991.8M
EBITDA	EUR 998.3M
EPS	EUR 17.03
F Score	2
Fiscal Year End	December
Founded	2,008
Graham Number	220.49479
Graham Upside	-67.08
Income Tax	EUR 10.3M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	700.4
Ma150ch	-4.38%
Ma20	686.5
Ma20ch	-2.43%
Next Earnings Date	2026-07-23
Open	671.6
Position In Range	52.17
Price Date	2026-05-08
Price EBITDA	EUR 36.09
Ptbv Ratio	6.75
Relative Volume	0.41x
Revenue	3,591,495,486x
Tax By Revenue	0.29x
Tax Rate	0.9%
Tr6m	-8.78%
Volume	15,976

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QW0 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QW0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QW0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

LON/0QW0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.1

Neutral momentum band

Price vs 200-day MA

-0.7%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

1.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QW0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QW0 stock rating?

lon/0QW0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QW0 analysis?

The full report lives at /stocks/lon/0QW0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QW0?

The latest report frames lon/0QW0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QW0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.